Oncology Archives - Page 13 of 23

Estimating and extrapolating survival using a state-transition modeling approach: a practical application in multiple myeloma

Authors: I Majer, S Kroep, R Maroun, C Williams, S Klijn, S Palmer Published: Value in Health, 2021 View publication Objectives State-transition models (STMs) applied in oncology have given limited considerations to...

Evaluation of minimal important difference and responder definition in the EORTC QLQ-PAN26 module for assessing health-related quality of life in patients with surgically resected pancreatic adenocarcinoma

Authors: M Reni, J Braverman, A Hendifar, C P Li, T Macarulla, D Y Oh, H Riess, M Tempero, B Lu, J Marcus, N Joshi, M Botteman, A C Dueck Published: Annals...

Cost effectiveness of axicabtagene ciloleucel versus tisagenlecleucel for adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy in the United States

Authors: R Liu , O O Oluwole , I Diakite , M F Botteman , J T Snider , F L Locke Published: Journal of medical economics, 2021 View publication Aims To...

Biosimilar pegfilgrastim may offer affordable treatment options for patients in France: a budget impact analysis on the basis of clinical trial and real-world data

Authors: J Yang, R Liu, A Granghaud, O Zaidi, J Stephens Published: Journal of medical economics, 2021 View publication Background NYVEPRIA, a pegfilgrastim (a long-acting granulocyte colony-stimulating factor [G-CSF]) biosimilar, was recently...

Non-small cell lung cancer symptom assessment questionnaire: psychometric performance and regulatory qualification of a novel patient-reported symptom measure

Authors: D M Bushnell, T M Atkinson, K P McCarrier, A M Liepa, K P DeBusk, S J Coons Published: Current therapeutic research, clinical and experimental, 2021 View publication Background The Non-Small...

Resource use associated with the management of docetaxel-related haematological toxicities, including neutropenic sepsis (NS), in patients with advanced non-small cell lung cancer (NSCLC) in the UK NHS: REVEAL-NS

Authors: T Talbot, A Dangoor, R Shah, J Naik, C Lees, J F Lester, R Cipelli, M Hodgson, A Patel, M Summerhayes, T Newsom-Davis Published: Lung Cancer, 2017 View publication

The rate of neutropenic sepsis (NS) and other haematological toxicities in patients with advanced non-small cell lung cancer (NSCLC) treated with docetaxel in the UK NHS: REVEAL-NS

Authors: T Talbot, A Dangoor, R Shah, J Naik, D Talbot, J F Lester, R Cipelli, M Hodgson, A Patel, M Summerhayes, T Newsom-Davis Published: Lung Cancer, 2017 View publication Introduction Following...

Cisplatin Use in UK Head and Neck Cancer Management: A Clinician Survey of Current Practice

Authors: B.H. Foran, J. Fenwick, B. Byrne, and J.A. Christian Published: 2017 View publication

The real world use of Bosutinib in patients with chronic myeloid leukaemia

Authors: J Apperley, J Byrne, G Smith, S Claudiani, J Janssen, A Viqueira, K Lang, A M Carter, G Nock, D Milojkovic Published: Blood, 2017 View publication Objectives Bosutinib is a second-generation tyrosine...